The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections

AIDS

Volumn 26, Issue 3, 2012, Pages 375-380

  Wand, Handan ^a   Ramjee, Gita ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

contraceptives; HIV; hormonal injectables; oral pills; South Africa; women

Indexed keywords

CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CHLAMYDIASIS; COHORT ANALYSIS; CONDOM; FEMALE; GONORRHEA; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; SEROCONVERSION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA;

CHLAMYDIA INFECTIONS; COHORT STUDIES; CONDOMS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; INJECTIONS; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX COUNSELING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA;

EID: 84855345105     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834f990f     Document Type: Article

References (30)

1. UNAIDS. Report on the global AIDS epidemic 2010. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2010.
2. Pettifor AE, Rees HV, Kleinschmidt I, Steffenson AE, MacPhail C, Hlongwa-Madikizela L, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 2005; 19:1525-1534. (Pubitemid 41400699)
3. McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet 2010; 376:1329-1337.
4. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372:1977-1987.
5. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999; 31:272-279. (Pubitemid 30004240)
6. Weller S, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002:CD003255.
7. Walsh TL, Frezieres RG, Peacock K, Nelson AL, Clark VA, Bernstein L, et al. Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials. Contraception 2004; 70:407-413. (Pubitemid 39422519)
8. Seiber EE, Bertrand JT, Sullivan TM. Changes in contraceptive method mix in developing countries. Int Fam Plan Perspect 2007; 33:117-123. (Pubitemid 350020559)
9. Curtis KM, Chrisman CE, Mohllajee AP, Peterson HB. Effective use of hormonal contraceptives Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants. Contraception 2006; 73:125-133. (Pubitemid 43087762)
10. Chrisman CE, Curtis KM, Mohllajee AP, Gaffield ME, Peterson HB. Effective use of hormonal contraceptives Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants. Contraception 2006; 73:125-133. (Pubitemid 43087762)
11. Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350:922-927. (Pubitemid 27420529)
12. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95. (Pubitemid 44912541)
13. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007; 36:166-174. (Pubitemid 47061592)
14. Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkmann U, Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr 1996; 12:500-507. (Pubitemid 26274941)
15. Martin HL, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-1059. (Pubitemid 28452198)
16. Bulterys M, Smith D, Chao A, Jaffe H. Hormonal contraception and incident HIV-1 infection: new insight and continuing challenges. AIDS 2007; 21:97-99. (Pubitemid 44912542)
17. Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, Mugerwa R, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010; 24:1778-1781.
18. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2011. doi: 10.1016/S1473-3099(11)70247-X.
19. Nunn A, McCormack S, Crook A, Pool R, Rutterford C, Hayes R. Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials 2009; 10:99.
20. Kibuuka H, Guwatudde D, Kimutai R, Maganga L, Maboko L, Watyema C, et al. Contraceptive use in women enrolled into preventive HIV vaccine trials: experience from a phase I/II trial in east Africa. PLoS One 2009; 4:e5164.
21. Sangi-Haghpeykar H, Posner SF, Poindexter AN. Consistency of condom use among low-income hormonal contraceptive users. Perspect Sex Reprod Health 2005; 37:184-191. (Pubitemid 43089511)
22. Chimbiri AM. The condom is an 'intruder' in marriage: evidence from rural Malawi. Soc Sci Med 2007; 64: 1102-1115. (Pubitemid 46209398)
23. Maharaj P. Patterns of condom use: perspectives of men in KwaZulu-Natal, South Africa. Dev South Afr 2005; 22:187-197. (Pubitemid 41110395)
24. Varga CA. Sexual decision-making and negotiation in the midst of AIDS: Youth in KwaZulu-Natal, South Africa. Health Transition Rev 1997; 2 (Suppl 3):45-67.
25. Padian N, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007; 370:251-261. (Pubitemid 47069513)
26. Vijayakumar G, Mabude Z, Smit J, Beksinska M, Lurie M. A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence. Int J STD AIDS 2006; 17:652-659. (Pubitemid 44611145)
27. Drew WL, Blair M, Miner RC, Conant M. Evaluation of the virus permeability of a new condom for women. Sex Transm Dis 1990; 17:110-112. (Pubitemid 20224336)
28. Peters A, Jansen W, van Driel F. The female condom: the international denial of a strong potential. Reprod Health Matters 2010; 18:119-128.
29. Warren M, Philpott A. Expanding safer sex options: introducing the female condom into national programmes. Reprod Health Matters 2003; 11:130-139. (Pubitemid 36687239)
30. CONRAD. Dual-protection technologies. http://www.conrad. org/research-technologies.html. [Accessed 28 July 2011]